INFLUX HEALTHTECH LIMITED Share Price

INFLUX HEALTHTECH LIMITED Share Price

NSE: INFLUX
|
Pharmaceuticals
₹ 271.00
-₹19.00 (-6.55%)
1D
Last updated 17 Jul, 2026, 15:28 IST

INFLUX HEALTHTECH LIMITED Share Price Today

As of 17 Jul 2026, INFLUX HEALTHTECH LIMITED share price is ₹271.00. The stock opened at ₹290.10, compared to its previous close of ₹290.00. During today's trading session, INFLUX HEALTHTECH LIMITED share price moved in the range of ₹270.00 to ₹291.00, with an average price of ₹280.50 for the day. Looking at its last 52-week, the stock has touched a low of ₹141.00 and a high of ₹315.00. On the performance front, INFLUX HEALTHTECH LIMITED share price has increased by 37.21% over the last six months and is up 79.68% on a year-on-year basis.

₹270.00
6.55% down today
₹291.00
1D LOW
1D HIGH

INFLUX HEALTHTECH LIMITED Returns Calculator

Open
₹290.10
High
₹291.00
Low
₹270.00
Prev. close
₹290.00
Circuit
L
H
₹232.00
₹348.00
52-week
L
H
₹141.00
₹315.00

INFLUX HEALTHTECH LIMITED Shareholder Returns

INFLUX HEALTHTECH LIMITED Share Price History

Mkt Cap Cr
671.36
P/E
32.69
P/B
6.66
ROE
20.39%
D/E
0.00
ROCE
27.21%
Div. Yield
0.00%
EPS(TTM)
9.35
Turnover
1.45
EV/EBITDA
—
Net Margin
0.00%
Op. Margin
0.00%
ROA
—
Quick Ratio
0.00
Curr. Ratio
3.59
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Influx Health. outperforming all market indices
Step 3 of 5
Valuation
Fairly Valued
Influx Health. appears to be fairly valued compared to its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,67,870.0036.735.0514.85%0.5518.72%18.850.91%0.5610.90
Divis Laboratories1,94,316.0075.6711.5915.32%0.0019.56%629.490.41%0.5898.19
Torrent Pharmaceuticals1,69,316.0066.0317.0326.76%1.0518.30%16.900.90%0.4964.75
Cipla1,15,477.0025.472.8711.79%0.0015.66%2.891.06%0.4943.52
Zydus Lifesciences1,15,062.0017.393.2319.69%0.3520.30%3.700.11%0.3935.38
Lupin1,14,310.0019.834.7127.01%0.0327.44%3.510.78%0.61129.18
Mankind Pharma1,05,107.001.050.1212.65%0.4212.97%5.050.05%0.5449.37
Dr. Reddy's Laboratories1,02,156.0024.972.7511.64%0.1513.65%3.320.64%0.6338.68
Aurobindo Pharma89,913.9025.672.379.25%0.1911.76%391.140.26%0.4841.58
Laurus Labs84,149.3060.2610.1018.21%0.4516.70%10.190.20%0.9713.72

INFLUX HEALTHTECH LIMITED Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026
Revenue148.16
Operating profit27.23
Net profit20.54

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹104.85₹99.97₹76.06₹59.20
Other Income₹0.13₹0.05₹0.00₹0.00
Total Revenue₹104.99₹100.02₹76.06₹59.20
Total Expenses₹87.11₹85.08₹66.32₹53.13
Profit Before Tax₹17.88₹14.93₹9.74₹6.07
Tax₹4.51₹3.80₹2.54₹1.57
Profit After Tax₹13.37₹11.13₹7.20₹4.50
EPS - Basic₹7.36₹6.13₹3.96₹1,801.90
EPS - Diluted₹7.36₹6.13₹3.96₹1,801.90

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹17.88₹14.93₹9.74₹6.07
Income before WC changes₹20.69₹17.21₹10.74₹6.20
Change in Assets-₹25.12-₹5.79-₹4.77-₹12.83
Change in Liabilities₹15.93₹0.47₹3.39₹12.20
Change in WC-₹9.20-₹5.32-₹1.38-₹0.63
Cash flow from Operations₹7.06₹8.94₹6.82₹4.29
Cash flow from Investing-₹8.64-₹8.36-₹4.88-₹3.41
Cash flow from Financing-₹0.11-₹0.53₹0.14₹0.56
Total Cash Flow-₹1.70₹0.06₹2.08₹1.44
Cash (Start of the year)₹3.61₹3.55₹1.47₹0.02
Cash (End of the year)₹1.91₹3.61₹3.55₹1.47

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹21.28₹15.42₹8.24₹3.29
Current Assets₹49.02₹25.68₹20.06₹14.30
Total Assets₹70.30₹41.10₹28.30₹17.59
Current Liabilities₹33.92₹17.98₹16.39₹12.47
Net Current Asset₹15.10₹7.70₹3.67₹1.83
Non-Current Liabilities₹0.23₹0.34₹0.26₹0.60
Equity Capital₹36.15₹22.78₹11.65₹4.53
Total Equity & Liabilities₹70.30₹41.10₹28.30₹17.59
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
282.15
1800
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 1800
Buy orders: 0%
Sell orders: 100%
Bearish
1
Neutral
4
Bullish
3
Slightly Bullish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
56.64
Neutral
ATR (14)
11.11
Neutral
STOCH(9,6)
3.85
Bullish
STOCH RSI (14)
0
Bullish
ADX(9)
42.98
Bearish
UO(9)
31.78
Neutral
ROC(12)
1.75
Bullish
WillR(14)
-68.49
Neutral
Period
Simple value
Exponential vaue
5D
294.14
293.22
10D
297.4
291.85
20D
281.49
283.32
50D
265.12
267.18
100D
246.2
253.84

About INFLUX HEALTHTECH LIMITED

INFLUX HEALTHTECH LIMITED Share Price
ISIN
INE0MYZ01012
Sector Market Cap
₹ 671.36 Cr

Influx Healthtech Limited is an India-based healthcare product-focused company. The Company operates as a contract development and manufacturing organization. It specializes in a diverse range of products across several segments, including dietary/nutritional supplements, cosmetics, ayurvedic/herbal, veterinary feed supplements and homecare segments. This includes the production of active pharmaceutical ingredients and the manufacturing of finished dosage forms such as tablets, capsules, and injectables. It manufactures dietary and nutritional supplements in the form of tablets, capsules, powders, liquid orals, soft gels, lozenges, jellies, oral dispersible films, candies, gummies and effervescent tablets, and others. It manufactures cosmetics products for men and women, which include skincare and body care products, hair care and beard care solutions, and face masks and soaps. It manufactures ayurvedic formulations in the form of tablets, capsules, powder, liquid orals and others.

INFLUX HEALTHTECH LIMITED Financial Highlights

  • Revenue: INFLUX HEALTHTECH LIMITED reported revenue of ₹148.16 crore in FY26 vs ₹104.98 crore in FY25. It showed an increase of 41.13% on a yearly basis.
  • Operating Profit: INFLUX HEALTHTECH LIMITED reported an operating profit of ₹27.23 crore in FY26 vs ₹17.71 crore in FY25. It showed an increase of 53.75% on a year-on-year basis.
  • Net Profit: INFLUX HEALTHTECH LIMITED reported a net profit of ₹20.54 crore in FY26 vs ₹13.27 crore in FY25. It showed an increase of 54.79% on a yearly basis.
Know more
Promoters
73.53%
FII
0.16%
Other DII
5.65%
Retail and other
20.66%
Mutual funds
0.00%
Foreign institutions - FII
Compare against other stocks
INFLUX HEALTHTECH LIMITED Share Price
INFLUX HEALTHTECH LIMITED
Pharmaceuticals
Add Stock
Add Another

FAQs on INFLUX HEALTHTECH LIMITED Share Price